Overview
What is Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc is a nonprofit organization based in West Conshohocken, Pennsylvania, dedicated to enhancing the global biopharmaceutical community's R&D of innovative therapies. Through collaborations, they identify, prioritize, design, and facilitate the implementation of solutions to improve the efficient, effective, and high-quality delivery of new medicines. With over 25 employees, Transcelerate Biopharma's initiatives include the Digital Data Flow (DDF) Initiative, Diversity of Participants in Clinical Trials Initiative, Modernizing Clinical Trial Conduct (MCTC) Initiative, Patient Experience (PE) Initiative, Site Qualification & Training (SQT) Initiative, Interpretation of Clinical Guidances & Regulations (IGR) Initiative, Modernization of Statistical Analytics (MOA) Initiative, Clinical Content & Reuse Initiative, and Privacy Methodology for Data Sharing Initiative. Their work spans various aspects of clinical trials, data sharing, and regulatory compliance to help biopharmaceutical companies bring new medicines to the market more efficiently.
Official website here: www.transceleratebiopharmainc.com
Is Transcelerate Biopharma Inc legitimate?
Transcelerate Biopharma Inc is a legitimate nonprofit organization registered as a 501(c)(6) entity. Transcelerate Biopharma Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are not tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $3,561,013
Professional Fundraising Fees: $0
Other Salaries and Wages: $4,460,754
For more financial information, click here
Official website here: www.transceleratebiopharmainc.com
What is the mission statement of Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc is a non-profit organization with a mission to improve global health by enhancing the research and development (R&D) of innovative new therapies. Through collaboration within the biopharmaceutical R&D community, Transcelerate identifies, prioritizes, designs, and facilitates the implementation of solutions that drive the efficient, effective, and high-quality delivery of new medicines. Membership in Transcelerate is open to biopharmaceutical companies with research and development operations.
Official website here: www.transceleratebiopharmainc.com
Who is the CEO of Transcelerate Biopharma Inc?
Janice Chang is the Ceo (Thru 12/31/2022) of Transcelerate Biopharma Inc. The CEO's salary of Transcelerate Biopharma Inc is $822,931 and their total compensation is $862,722.
Official website here: www.transceleratebiopharmainc.com
What is the revenue of Transcelerate Biopharma Inc?
Transcelerate Biopharma Inc's revenue in 2022 was $33,600,302.
Official website here: www.transceleratebiopharmainc.com
Who are the executives of Transcelerate Biopharma Inc and what are their salaries?
The average compensation at Transcelerate Biopharma Inc during 2022 was $320,871. There are 25 employees and 29 volunteers at Transcelerate Biopharma Inc.
Here are 36 key members and their salaries (Transcelerate Biopharma Inc's CEO's salary is $822,931 and their total compensation is $862,722):
- Dalvir Gill (Ceo (Thru 12/31/2022)) [Trustee/Director]
- Janice Chang (Coo (Ceo Eff 01/01/2023))
- Jennifer A Burgess (Vp Global Engagement And Comms)
- Cara L Rinaldi (Vp Of Portfolio Management)
- Anthony Garges (Head Of Finance And Administration)
- Jeneen Donadeo (Exec. Director Of Portfolio Management)
- Robert Dicicco (Vp Of Portfolio Management)
- Kathryn Owen (Chair Of Board Of Director)
- Badhri Srinivasan (Vice Chair Of Board Of Director)
- Eliav Barr (Board Member (Eff 04/2022)) [Trustee/Director]
- Dietmar Berger (Board Member) [Trustee/Director]
- Uli Broedl (Board Member (Eff 02/2022)) [Trustee/Director]
- Chris Corsico (Board Member) [Trustee/Director]
- Christoph Koenen (Board Member (Eff 04/2022)) [Trustee/Director]
- Maria Koutsopoulou (Board Member (Eff 04/2022)) [Trustee/Director]
- Bari Kowal (Board Member (Eff 01/2022)) [Trustee/Director]
- Martin Holst Lange (Board Member) [Trustee/Director]
- Rob Lenz (Board Member) [Trustee/Director]
- Iris Loew-Friedrich (Board Member) [Trustee/Director]
- Cristian Massacesi (Board Member) [Trustee/Director]
- Robert Metcalf (Board Member) [Trustee/Director]
- William Pao (Board Member (Eff 05/2022)) [Trustee/Director]
- Michelle Rohrer (Board Member) [Trustee/Director]
- Mokash Sharma (Board Member (Eff 12/2022)) [Trustee/Director]
- Tadaaki Taniguchi (Board Member (Eff 10/2022)) [Trustee/Director]
- Takuko Yamada-Sawada (Board Member) [Trustee/Director]
- Andrew Lee (Treasurer)
- Robert Baker (Secretary (Thru 12/2022))
- Roy Baynes (Board Member (Thru 04/2022)) [Trustee/Director]
- Rod Mackenzie (Board Member (Thru 04/2022)) [Trustee/Director]
- John Oidtman (Board Member (Thru 04/2022)) [Trustee/Director]
- Stuart Poulton (Board Member (Thru 01/2022)) [Trustee/Director]
- Steffen Roellinger (Board Member (Thru 01/2022)) [Trustee/Director]
- Peter Ronco (Board Member (Thru 10/2022)) [Trustee/Director]
- Mehdi Shahidi (Board Member (Thru 02/2022)) [Trustee/Director]
- Bernhardt G Zeiher (Board Member (Thru 09/2022)) [Trustee/Director]
Official website here: www.transceleratebiopharmainc.com
Where can I find the form 990 for Transcelerate Biopharma Inc?
The Transcelerate Biopharma Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.transceleratebiopharmainc.com
Learn more at the official website: www.transceleratebiopharmainc.com
Mission Statement of Transcelerate Biopharma Inc
Transcelerate Biopharma Inc, a non-profit organization, is committed to enhancing the global biopharmaceutical community's research and development (R&D) of innovative new therapies. With a mission to collaborate across the industry, Transcelerate Biopharma aims to identify, prioritize, design, and facilitate the implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. By bringing together biopharmaceutical companies with research and development operations, Transcelerate Biopharma fosters a collaborative environment that accelerates the process of bringing groundbreaking therapies to the world. Together, members of Transcelerate Biopharma work towards improving health outcomes for people around the globe. Through their collective efforts, the organization identifies key challenges in the R&D process, designs and implements solutions, and facilitates their implementation to ensure the timely and efficient delivery of new medicines. Transcelerate Biopharma's collaborative approach creates a powerful network of industry experts, driving innovation and advancing the development of life-changing therapies.
Impact
This information is meant to be a general summary of Transcelerate Biopharma Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Transcelerate Biopharma Inc's impact is significant in improving the health of people worldwide through its dedicated efforts to accelerate and enhance the research and development of innovative therapies. In 2022, Transcelerate delivered a range of accomplishments that showcased its commitment to driving the efficient, effective, and high-quality delivery of new medicines. Initiatives such as the Digital Data Flow, Diversity of Participants in Clinical Trials, Modernizing Clinical Trial Conduct, Patient Experience, and many others have established Transcelerate as a key player in advancing the biopharmaceutical research and development community. Through collaborations and the release of various resources and tools, Transcelerate is instrumental in shaping the future of clinical trials, patient engagement, data sharing, pharmacovigilance, and more. The organization's impact extends beyond individual projects to influence industry standards and best practices, ultimately benefiting the broader global health landscape.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
MEMBERSHIP DUES
Revenue
$33,532,000
Organization Details
Founding Year
2012
Phone
(484) 539-1230
Principal Officer
Janice Chang
Main Address
300 CONSHOHOCKEN STATE ROAD 420, WEST CONSHOHOCKEN, PA, 19428
NTEE Category
Code: H99 - Medical research
If you are a representative of Transcelerate Biopharma Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.